Ocrevus Zunovo (ocrelizumab / hyaluronidase) is an injection that's given under the skin (subcutaneous). It's used to treat multiple sclerosis (MS) in adults. Ocrevus Zunovo is a monoclonal antibody. It also contains an enzyme called hyaluronidase that makes it easier for the medication to absorb through the skin. The injection is given every 6 months by a healthcare professional at a medical center or clinic. Side effects include injection-site reactions like pain, itching, and redness. You might also have a headache and feel nauseous.
Ocrevus Zunovo has two active ingredients in it.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
You'll probably take Ocrevus Zunovo as long as it's helping your MS. Along with this, you'll probably keep taking it as long as you're not having any serious side effects from it. So far in studies, people have taken Ocrevus Zunovo for almost 2 years. And people have received Ocrevus (the version of the medication that's given as an infusion into the vein) for up to 9 years. Ask your prescriber if you have questions about how long to take Ocrevus Zunovo.
Ocrevus Zunovo is administered as an injection under the skin of the stomach. A trained healthcare professional will help inject the medication. They'll be careful to avoid areas that are red, bruised, tender, or hard, as well as places with moles or scars. You'll need to go to the medical center or clinic to get your Ocrevus Zunovo injection. Talk to your care team to learn more about how this medication is given.
No, Ocrevus Zunovo doesn't usually cause weight gain. Talk to your prescriber or primary care provider if you notice any changes in weight while taking this medication. They can help you figure out what's causing this.
If you're pregnant or thinking of getting pregnant, talk to your prescriber. They can help you understand the risks and benefits of taking Ocrevus Zunovo. Animal studies show that ocrelizumab might harm an unborn baby when given as an injection into the vein during pregnancy. But it's still important to keep MS relapses low while pregnant. Your prescriber can help you decide the safest option for you. Tell your prescriber right away if you get pregnant during treatment or within 6 months of your last injection.
If you're thinking about breastfeeding while taking Ocrevus Zunovo, talk to your prescriber. They can help explain the risks and benefits. We don't know for sure how safe the medication is for you or your baby when breastfeeding. Talk to your prescriber or a lactation specialist about your feeding choices while taking Ocrevus Zunovo.
Ocrevus and Ocrevus Zunovo both treat multiple sclerosis (MS). They both have the same active ingredient, ocrelizumab. They have similar safety risks. And they're also both given as injections every 6 months by a trained nurse. But they're given in different ways. Ocrevus is an intravenous infusion, meaning it's injected into a vein over a few hours. But Ocrevus Zunovo is an injection that's given under the skin in your stomach. The injection itself takes about 10 minutes. Ocrevus Zunovo contains an extra active ingredient called hyaluronidase. It helps your body absorb the medication from under the skin better. You generally spend less time at the clinic for Ocrevus Zunovo than for Ocrevus. Talk to your prescriber to compare and see which option is right for you.
Ocrevus Zunovo can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Some people can have a reaction after they get their Ocrevus Zunovo injection. Local reactions include pain, redness, swelling, and itchiness at the injection site. But you could also have reactions like headache, flushing, and nausea.
Other reactions might be possible. They can include fever, itchiness, hives, pain in the mouth or throat, a fast heart rate, and other signs of anaphylaxis. Reactions like neck swelling and trouble breathing can be very serious. These reactions have happened when ocrelizumab is given as an infusion into the vein. But it's important to be aware that they might happen with Ocrevus Zunovo (the version that's injected under the skin).
Your care team might give you a few medications at least 30 minutes before your Ocrevus Zunovo injection. They might give you a steroid and an antihistamine. They also might give you acetaminophen (Tylenol). This helps lower the risk and severity of injection reactions.
The nurse will watch for reactions while you're getting Ocrevus Zunovo injected. But let them know if you have any reactions at any time during your injection. They can give you medications to help.
Your care team will also watch you for at least another hour after your first injection. Then, they'll watch for at least 15 minutes after your next injections. This helps them look for and attend to any delayed reactions. Reactions can happen up to a day after the injection. So, get medical help right away if you have an injection reaction when you're back at home.
Ocrevus Zunovo can weaken your immune system and make it harder to fight off germs. This can raise your risk of getting infections from bacteria, viruses, or fungi. Some infections include upper respiratory infections and urinary tract infections. Sometimes, infections can be very serious. For example, it's rare but possible to get a serious brain infection called progressive multifocal leukoencephalopathy (PML).
Before starting Ocrevus Zunovo, tell your prescriber about your medical history. If you're sick, don't start treatment until you get better. Your prescriber will also check for hepatitis B. This infection can come back during treatment and cause serious problems. Your prescriber will make sure this medication is safe for you.
Also let your prescriber know about all the medications you take. It's important to check if you take other medications that can weaken your immune system. This can raise your risk of infections even higher.
Call your care team if you think you have an infection. Watch for a fever, chills, a cough, trouble breathing, weakness, or a rash. Also take note if it hurts when you urinate or if you feel the need to urinate more often. If you're sick, you might need to stop treatment until you're better.
Get medical help right away if you feel weak on one side, have vision changes, feel clumsy, or have trouble thinking or remembering. These could be signs of a serious brain infection that needs medical care.
It's possible for Ocrevus Zunovo to lower the levels of certain immunoglobulins (antibodies) in your body. This might put you at risk of serious infections.
Your prescriber will check your antibody levels with blood tests while you're taking Ocrevus Zunovo. They'll keep checking even after you stop until your levels are back to normal. If your antibody levels are too low, your care team can help decide what to do next. For example, immunoglobulin infusions might help bring your levels up.
Although rare, some people who received ocrelizumab as an infusion into the vein had colitis. This is when the colon gets inflamed or swollen. It's happened from a few weeks to years of starting the medication. Some cases have been serious and needed other medications to help treat it. Sometimes, people needed to go to the hospital or get surgery for this problem.
Your prescriber will monitor you for this gut problem while you're taking Ocrevus Zunovo. Tell your care team right away if you have stomach pain, cramping, diarrhea, or bloody stools. They can see if there's something serious going on.
It's rare, but there might be a possible higher risk of cancer with Ocrevus Zunovo. In studies, cases of cancer, including breast cancer, happened more often in people who received ocrelizumab as an infusion into the vein. This was in comparison to those who took either a different MS medication or placebo.
Talk to your prescriber about the risk of cancer with Ocrevus Zunovo. They can talk to you about getting screened for cancer, including any tests or exams you might need. They can also tell you the signs of cancer to watch for during treatment. Call your care team if you notice anything unusual.
The typical dose is 920 mg/23,000 units (ocrelizumab / hyaluronidase) injected under the skin of the stomach every 6 months.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Ocrevus Zunovo will not be safe for you to take.